SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 72 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $21,000 | -19.2% | 2,816 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $26,000 | +73.3% | 2,816 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | 0.0% | 2,816 | -16.3% | 0.00% | – |
| Q4 2018 | $15,000 | -94.3% | 3,366 | -91.0% | 0.00% | -100.0% |
| Q2 2018 | $263,000 | -48.0% | 37,444 | +5.3% | 0.01% | -45.5% |
| Q1 2018 | $506,000 | +62.2% | 35,574 | 0.0% | 0.01% | +57.1% |
| Q4 2017 | $312,000 | -32.5% | 35,574 | -10.0% | 0.01% | -36.4% |
| Q3 2017 | $462,000 | -10.6% | 39,512 | +6.7% | 0.01% | -15.4% |
| Q2 2017 | $517,000 | +69.0% | 37,026 | +65.8% | 0.01% | +62.5% |
| Q1 2017 | $306,000 | +91.2% | 22,330 | 0.0% | 0.01% | +100.0% |
| Q4 2016 | $160,000 | – | 22,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |